MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-24-0002835
Centurion Laboratories Private Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹208.27 Cr
▲ 35% YoY
Net profit · FY 2024
₹10.91 Cr
Net margin 5.2%
EBITDA · FY 2024
₹18.52 Cr
EBITDA margin 8.9%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Open charges
₹111.08 Cr
Satisfied ₹153.82 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
289
Provident fund records
About Centurion Laboratories Private Limited
Data last updated:
Centurion Laboratories Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 December 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U73100GJ2006PTC049620. Its GSTIN is 24AACCT7761J1Z2 (Gujarat).
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4 Cr. It was formerly known as Total Potential Cell Private Limited. It is led by directors Mahipat Ambalalbhai Patel and Chandrakant Patel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at G/6 Industrial Estate Gorwa, Vadodara, Gujarat, India – 390016.
As per the financials filed for FY 2024, the company reported a revenue of ₹208.27 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹10.91 Cr (net margin 5.2%) and EBITDA of ₹18.52 Cr (EBITDA margin 8.9%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 23% over five years.
The company has about 289 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Cenforce Australia and Vidalista. As per MCA filings, the company has open charges of ₹111.08 Cr and satisfied charges of ₹153.82 Cr on record. Court records list 50 cases involving the company, including 17 filed by the company and 33 filed against it; 19 cases are pending. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹7.98 Cr; the latest was in March 2017. The company has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 20 overdue payments to 6 micro and small suppliers.
Centurion Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0002835). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website centurionlaboratories.com.
Company details
CIN U73100GJ2006PTC049620
Registration Number 049620
Incorporation Date 21 December 2006
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-24-0002835
Recognitions & Rankings of Centurion Laboratories
Contact details
Centurion Laboratories Private Limited's registered office is in Vadodara, Gujarat. Its website is centurionlaboratories.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressG/6 Industrial Estate Gorwa, Vadodara, Gujarat, India – 390016
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Centurion Laboratories Private Limited, buy the company report.
Comprehensive company report
Centurion Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Centurion Laboratories operates two associated brands: Cenforce Australia and Vidalista. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online supply of erectile dysfunction medications in Australia. | cenforce-australia.com | |
| Online sales of erectile dysfunction medications, including various dosages of Vidalista. | vidalista-20.com |
Financials of Centurion Laboratories Private Limited
FY 2024 filings availableCenturion Laboratories Private Limited reported revenue of ₹208.27 Cr (up 35% YoY) for FY 2024.
Revenue · FY 2024
₹208.27 Cr ▲ 35%
Net profit · FY 2024
₹10.91 Cr margin 5.2%
EBITDA · FY 2024
₹18.52 Cr margin 8.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 24%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▲ 84%
3 years · compounded
▲ 41%
5 years · compounded
▲ 47%
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 35% growth in the latest year. EBITDA rose 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹208.27 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.52 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.91 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | ||||
| Net Profit Margin | 5.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Centurion Laboratories Private Limited, buy the company report.
Board of directors of Centurion Laboratories Private Limited
Centurion Laboratories has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahipat Ambalalbhai Patel Also directs: Curventis Laboratories LLP, Centurion Research Private Limited, Centurion Remedies Private Limited and 1 more | Director | 20 Feb 2013 | 13 Years 8 Months | Current |
| Chandrakant Patel | Additional Director | 01 Apr 2025 | 1 Years 6 Months | Current |
Auditor
Centurion Laboratories Private Limited is audited by SURTI & TALATI for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURTI & TALATI | FY 2024 | 114924W |
Shareholding
The shareholding of Centurion Laboratories Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Centurion Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹111.08 Cr
Satisfied charges
₹153.82 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Jun 2024 | 100945051 | Others | ₹47.21 Lakh | Open | |
| 20 Jun 2024 | 100941328 | Others | ₹9.46 Lakh | Open | |
| 31 Mar 2024 | 100908031 | Hdfc Bank Limited | ₹110.52 Cr | Open | |
| 05 Mar 2022 | 100560574 | Hdfc Bank Limited | ₹8 Cr | Satisfied | |
| 02 Apr 2021 | 100445177 | Others | ₹14.7 Cr | Satisfied |
To see the full charge records of Centurion Laboratories Private Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Centurion Laboratories Private Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹7.98 Cr; the latest was in March 2017.
Total deals
4
Secondary share transfers
3
Funding round
1
Disclosed funding
₹7.98 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Mar 2013 | Funding round | ₹7.98 Cr | Investors: 4 individuals |
| Jun 2011 | Secondary share transfer | Undisclosed | Buyer: Ambalal Vanarasidas Patel (HUF) Seller: an individual |
| Jan 2011 | Secondary share transfer | Undisclosed | Buyer: Centurion Remedies Private Limited Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Centurion Laboratories Private Limited has 50 court cases on record: 17 filed by Centurion Laboratories, 33 filed against it. 19 cases are pending and 31 are disposed.
Total cases
50
Filed by the company
17
Filed against the company
33
Pending
19
Disposed
31
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 26 | 22 | 10 |
| High courts | 18 | 5 | 5 |
| NCLAT | 4 | 4 | 4 |
| Supreme Court | 1 | 1 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 50)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed against the company by M/S. Hetero Labs Ltd., Rep. by Mr. N. Balamaheswar Reddy | Pending |
| High Court | Interim or miscellaneous application | Filed against the company by Ajanta Pharma Limited W.S. Kane and Co | Pending |
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed against the company by M/S. Hetero Labs Ltd., Rep. by Mr. N. Balamaheswar Reddy | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Ajanta Pharma Limited | Pending |
| Bombay High Court | Writ petition | Filed by the company against Anm Pharma Pvt Ltd and 1 other | Pending |
To see the full case history of Centurion Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Centurion Laboratories Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 20 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Atharva Packaging Private Limited | |||
| Deval Polymers | |||
| Mehta Pharmaceutical Industries | |||
| an individual supplier | |||
| Vaikunth Chemicals Pvt Ltd |
To see the full MSME payment records of Centurion Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Centurion Laboratories Private Limited has a workforce of 289 employees on its EPFO records as of Dec 08, 2025, across 1 active EPFO establishment.
Employee count
289
Active EPFO establishments
1
Employee growth
2.48%
GST
Centurion Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCT7761J1Z2 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Centurion Laboratories Private Limited, buy the company report.
Recent activity
Centurion Laboratories Private Limited has 8 board changes on record since 2011: 3 appointments and 5 cessations. The latest: Chandrakant Patel was appointed as Additional Director on 01 Apr 2025.
Appointed
Chandrakant Patel was appointed as Additional Director.
Charges
A charge registered on 21 Oct 2020 via Charge ID 100400690 with Others was fully satisfied on 19 Nov 2024.
Charges
A charge registered on 11 Jul 2014 via Charge ID 10512696 with Others was fully satisfied on 19 Nov 2024.
Charges
A charge registered on 19 Jun 2014 via Charge ID 10512454 with Others was fully satisfied on 19 Nov 2024.
AGM
Centurion Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 05 Mar 2022 via Charge ID 100560574 with Hdfc Bank Limited was fully satisfied on 03 Jul 2024.
Charges
A charge with Others amounted to Rs. 0.47 Cr with Charge ID 100945051 was registered on 26 Jun 2024.
Charges
A charge with Others amounted to Rs. 0.09 Cr with Charge ID 100941328 was registered on 20 Jun 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 110.52 Cr registered on 31 Mar 2024 with Charge ID 100908031 was modified on 03 Jun 2024.
Filing
Centurion Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 110.52 Cr with Charge ID 100908031 was registered on 31 Mar 2024.
Charges
A charge registered on 02 Apr 2021 via Charge ID 100445177 with Others was fully satisfied on 03 Feb 2024.
21 earlier events are in the company report.
Frequently asked questions
Centurion Laboratories is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 December 2006 (20+ years old) and is registered under CIN U73100GJ2006PTC049620.
Centurion Laboratories has 2 current directors:
- Mahipat Ambalalbhai Patel - Director
- Chandrakant Patel - Additional Director
The latest financial statements of Centurion Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Centurion Laboratories is 24AACCT7761J1Z2, registered in Gujarat.
The CIN (Corporate Identification Number) of Centurion Laboratories is U73100GJ2006PTC049620. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Centurion Laboratories has 50 court cases on record: 17 filed by the company and 33 filed against it. 19 are pending. Most are in the district courts.
Centurion Laboratories was incorporated on 21 December 2006, making it 20+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Centurion Laboratories has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹7.98 Cr; the latest was in March 2017.
Chandrakant Patel was appointed as Additional Director on 01 Apr 2025. Hemin Bhaskarbhai Patel ceased to be Additional Director on 30 Sep 2017. Ambalal Vanarasidas Patel ceased to be Additional Director on 30 Sep 2015. Centurion Laboratories has 8 board changes on record in total.
Yes, Centurion Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-24-0002835).
Centurion Laboratories has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 20 overdue payments to 6 micro and small suppliers. The latest return was filed on 08 Jun 2019.